These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 11022927)

  • 1. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.
    Takayama T; Sekine T; Makuuchi M; Yamasaki S; Kosuge T; Yamamoto J; Shimada K; Sakamoto M; Hirohashi S; Ohashi Y; Kakizoe T
    Lancet; 2000 Sep; 356(9232):802-7. PubMed ID: 11022927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
    Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
    Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
    Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
    Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatocellular carcinoma recurrence: actuality and perspectives.
    Takayama T; Makuuchi M
    Hepatogastroenterology; 2002; 49(43):87-90. PubMed ID: 11941990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
    Peng B; Liang L; Chen Z; He Q; Kuang M; Zhou F; Lu M; Huang J
    Hepatogastroenterology; 2006; 53(69):409-14. PubMed ID: 16795983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
    Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
    Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.
    Weng DS; Zhou J; Zhou QM; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Wu PH; Xia JC
    J Immunother; 2008 Jan; 31(1):63-71. PubMed ID: 18157013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.
    Yoon JS; Song BG; Lee JH; Lee HY; Kim SW; Chang Y; Lee YB; Cho EJ; Yu SJ; Sinn DH; Kim YJ; Lee JH; Yoon JH
    BMC Cancer; 2019 May; 19(1):523. PubMed ID: 31151419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of autologous tumor vaccine in preventing recurrence of hepatocellular carcinoma].
    Peng BG; Liang LJ; He Q; Zhou F; Lai JM; Lü MD; Huang JF
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):772-5. PubMed ID: 16248952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma].
    Gao J; Chen M; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):432-5. PubMed ID: 15975277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma.
    Makino I; Chijiiwa K; Kondo K; Ohuchida J; Kai M
    Surgery; 2005 Jun; 137(6):626-31. PubMed ID: 15933630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].
    Lü MD; Kuang M; Liang LJ; Xie XY; Peng BG; Liu GJ; Li DM; Lai JM; Li SQ
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):801-5. PubMed ID: 16681964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
    Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.